Page last updated: 2024-08-23

epirubicin and Ventricular Dysfunction, Left

epirubicin has been researched along with Ventricular Dysfunction, Left in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (42.31)29.6817
2010's14 (53.85)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
Adam, G; Azar, M; Beitzen-Heineke, A; Goy, Y; Lund, GK; Molwitz, I; Muellerleile, K; Müller, V; Petersen, C; Schön, G; Seiffert, K; Shihada, S; Stehning, C; Tahir, E1
Geisler, J; Gravdehaug, B; Gulati, G; Hagve, TA; Heck, SL; Hoffmann, P; Norseth, J; Omland, T; Ree, AH; Røsjø, H; Steine, K1
Chen, F; Chen, H; He, B; Kang, Y; Shen, L; Shen, X; Wang, W; Xiao, F; Zhao, H1
Jiang, Y; Peng, Q; Tang, Z; Zhou, Q1
Enescu, OA; Florescu, M; Jinga, D; Magda, LS; Vinereanu, D1
Aftimos, P; Ameye, L; Beauduin, M; Bejarano Hernández, S; Cornez, N; de Azambuja, E; Delhaye, F; Diaz, M; Focan, C; Lemort, M; Paesmans, M; Piccart-Gebhart, M; Shih-Li, C; Suter, T; Vandenbossche, S; Vindevoghel, A1
Han, Q; Hu, R; Irwin, DM; Li, H; Man, Z; Mao, Y; Niu, G; Tan, H; Wang, X; Zhang, J; Zhang, Q; Zhang, X1
Cadeddu, C; Colonna, P; Dessì, M; Hagendorff, A; Madeddu, C; Mantovani, G; Mercuro, G; Piras, A; Scartozzi, M1
Bi, X; Deng, Y; Li, C; Wu, Y; Zeng, F; Zhao, C; Zhu, Y1
Albrile, F; Biggi, A; Bobbio, M; Feola, M; Francini, A; Garrone, O; Merlano, M; Occelli, M; Visconti, G1
Caron, HN; Hauptmann, M; Kok, WE; Koning, CC; Kremer, LC; Oldenburger, F; van Dalen, EC; van den Bos, C; van der Pal, HJ; van Leeuwen, FE1
Cadeddu, C; Deidda, M; Dessì, M; Madeddu, C; Mantovani, G; Massa, E; Mercuro, G; Piras, A1
Appel, JM; Mortensen, CE; Nielsen, DL; Skagen, K; Sogaard, P1
Adoh, A; Adoubi, I; Adoubi, K; Anzouan-Kacou, JB; Didi-Kouko, C; Pio, M; Tegnan, A1
AitRaiss, M; Benhmidoun, MA; Derhem, N; Elalouani, C; Elguenzri, A; Elhattaoui, M; Elomrani, A; Errehmouni, A; Faouzi, R; Khouchani, M; Mahmal, L; Rida, H; Tahri, A; Tazi, I1
Deng, LC; Gao, CH; Shen, D; Shen, WS; Zhang, H1
Carrió, I; Dalesio, O; Estorch, M; Hoefnagel, CA; López-Pousa, J; ten Bokkel Huinink, WW; Valdés Olmos, RA1
Aldrighetti, D; Baldini, E; Bolognesi, A; Bruzzi, P; Carnino, F; Conte, PF; Gallo, L; Giannessi, P; Orlandini, C; Prochilo, T; Rosso, R; Salvadori, B; Venturini, M1
Barats, JC; Bonneterre, J; Chapelle-Marcillac, I; Clavère, P; Datchary, J; Fargeot, P; Fumoleau, P; Goudier, MJ; Kerbrat, P; Monnier, A; Montcuquet, P; Roché, H; Van Praagh, I; Veyret, C1
Azarnia, N; Chan, S; Davidson, N; Erdkamp, F; Juozaityte, E; Lee, LW; Pluzanska, A1
Bonneterre, J; Fargeot, P; Fumoleau, P; Goudier, MJ; Kerbrat, P; Luporsi, E; Monnier, A; Montcuquet, P; Namer, M; Roché, H; Romestaing, P1
Cadeddu, C; Deidda, M; Dessì, M; Madeddu, C; Mantovani, G; Massa, E; Mercuro, G; Piras, A; Serpe, R1
Duncea, C; Pripon, S; Radulescu, D; Radulescu, LI1
Bengala, C; Carnino, F; Conte, P; Del Mastro, L; Gallo, L; Lionetto, R; Michelotti, A; Montanaro, E; Rosso, R; Tibaldi, C; Venturini, M1
Boyer, M; Gurney, H; Lewis, C; McKendrick, J; Millward, M; Richardson, G; Rischin, D; Smith, J; Toner, G1
Baccheta, G; Belotti, G; Ciotti, R; Cremonesi, M; Facchi, E; Gatti, C; Ucci, G1

Trials

14 trial(s) available for epirubicin and Ventricular Dysfunction, Left

ArticleYear
Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study.
    Journal of the American Heart Association, 2017, Nov-08, Volume: 6, Issue:11

    Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers; Antibiotics, Antineoplastic; Benzimidazoles; Biomarkers; Biphenyl Compounds; Breast Neoplasms; Cardiotoxicity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epirubicin; Female; Humans; Metoprolol; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Protein Precursors; Tetrazoles; Treatment Outcome; Troponin I; Troponin T; Ventricular Dysfunction, Left

2017
Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2014, Volume: 27, Issue:1

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Early Diagnosis; Echocardiography; Elasticity Imaging Techniques; Epirubicin; Female; Humans; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left

2014
Cardiac assessment of early breast cancer patients 18 years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapy.
    European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:17

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Echocardiography; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Prognosis; Proportional Hazards Models; Survival Rate; Ventricular Dysfunction, Left

2015
Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide.
    International journal of cardiology, 2011, Apr-14, Volume: 148, Issue:2

    Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Breast Neoplasms, Male; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Stroke Volume; Troponin I; Ventricular Dysfunction, Left

2011
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.
    American heart journal, 2010, Volume: 160, Issue:3

    Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Antibiotics, Antineoplastic; Benzimidazoles; Benzoates; Cytokines; Echocardiography, Doppler; Epirubicin; Female; Heart; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Myocardial Contraction; Oxidative Stress; Renin-Angiotensin System; Systole; Telmisartan; Ventricular Dysfunction, Left

2010
Tissue-Doppler assessment of cardiac left ventricular function during short-term adjuvant epirubicin therapy for breast cancer.
    Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2011, Volume: 24, Issue:2

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Chemotherapy, Adjuvant; Epirubicin; Female; Humans; Middle Aged; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left

2011
Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer.
    Drugs in R&D, 2012, Jun-01, Volume: 12, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antioxidants; Breast Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Epirubicin; Female; Glucosides; Humans; Middle Aged; Phenols; Reactive Oxygen Species; Rhodiola; Ventricular Dysfunction, Left

2012
High sensitivity of radiolabelled antimyosin scintigraphy in assessing anthracycline related early myocyte damage preceding cardiac dysfunction.
    Nuclear medicine communications, 2002, Volume: 23, Issue:9

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Doxorubicin; Epirubicin; Follow-Up Studies; Heart; Humans; Indium Radioisotopes; Middle Aged; Myocardium; Myocytes, Cardiac; Myosins; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Stroke Volume; Ventricular Dysfunction, Left

2002
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safety.
    British journal of cancer, 2004, Jul-05, Volume: 91, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Epirubicin; Female; Heart Failure; Humans; Middle Aged; Neoplasm Metastasis; Paclitaxel; Risk Factors; Ventricular Dysfunction, Left

2004
Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Aug-01, Volume: 22, Issue:15

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Heart; Heart Failure; Humans; Lymphatic Metastasis; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Dysfunction, Left

2004
Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease Progression; Doxorubicin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Liposomes; Middle Aged; Neoplasm Metastasis; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left

2004
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    The oncologist, 2007, Volume: 12, Issue:9

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Biomarkers; Creatine Kinase; Echocardiography, Doppler; Epirubicin; Female; Glutathione Peroxidase; Heart Failure; Humans; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Myocardial Contraction; Myoglobin; Natriuretic Peptide, Brain; Oxidative Stress; Reactive Oxygen Species; Receptors, Interleukin-6; Stroke Volume; Troponin I; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Septum

2007
Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients.
    Breast cancer research and treatment, 2000, Volume: 59, Issue:2

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Cardiovascular Agents; Epirubicin; Female; Heart Failure; Humans; Injections, Intravenous; Middle Aged; Razoxane; Treatment Outcome; Ventricular Dysfunction, Left

2000
A phase II trial of paclitaxel and epirubicin in advanced breast cancer.
    British journal of cancer, 2000, Volume: 83, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Epirubicin; Female; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Paclitaxel; Stroke Volume; Survival Analysis; Ventricular Dysfunction, Left

2000

Other Studies

12 other study(ies) available for epirubicin and Ventricular Dysfunction, Left

ArticleYear
Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT.
    European radiology, 2022, Volume: 32, Issue:3

    Topics: Breast Neoplasms; Cardiotoxicity; Epirubicin; Female; Heart Diseases; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Predictive Value of Tests; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left

2022
Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
    Arquivos brasileiros de cardiologia, 2018, Volume: 110, Issue:3

    Topics: Adult; Aged; Analysis of Variance; Anthracyclines; Antibiotics, Antineoplastic; Cardiotoxicity; Case-Control Studies; Cross-Sectional Studies; Echocardiography; Epirubicin; Female; Follow-Up Studies; Heart; Humans; Lymphoma, B-Cell; Male; Middle Aged; Myocardium; Observer Variation; Reference Values; Risk Factors; Statistics, Nonparametric; Stroke Volume; Ventricular Dysfunction, Left; Young Adult

2018
[Velocity vector imaging assessment of early epirubicin-induced myocardial damage].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2013, Volume: 38, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Flow Velocity; Breast Neoplasms; Carcinoma, Ductal, Breast; Cardiac Volume; Case-Control Studies; Echocardiography; Elasticity Imaging Techniques; Epirubicin; Female; Humans; Middle Aged; Ventricular Dysfunction, Left

2013
Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy.
    Journal of ethnopharmacology, 2016, Nov-04, Volume: 192

    Topics: Animals; Autophagy; Cardiotonic Agents; Cardiotoxicity; Collagen; Disease Models, Animal; Drugs, Chinese Herbal; Epirubicin; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Heart Diseases; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 9; Myocardium; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Stroke Volume; Time Factors; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2016
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy.
    The international journal of cardiovascular imaging, 2017, Volume: 33, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cardiotoxicity; Drug Administration Schedule; Drug Synergism; Early Diagnosis; Echocardiography, Doppler, Pulsed; Epirubicin; Female; Humans; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Prospective Studies; Risk Factors; Time Factors; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left

2017
Evaluation of epirubicin-induced cardiotoxicity by two-dimensional strain echocardiography in breast cancer patients.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2009, Volume: 29, Issue:3

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Breast Neoplasms; Echocardiography, Doppler; Epirubicin; Female; Humans; Middle Aged; Ventricular Dysfunction, Left; Ventricular Function, Left

2009
Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study.
    Archives of internal medicine, 2010, Jul-26, Volume: 170, Issue:14

    Topics: Adolescent; Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Doxorubicin; Echocardiography; Epirubicin; Female; Follow-Up Studies; Humans; Infant; Linear Models; Logistic Models; Male; Multivariate Analysis; Neoplasms; Netherlands; Prevalence; Prospective Studies; Risk Factors; Ventricular Dysfunction, Left

2010
[Early detection of anthracyclines cardiotoxicity by tissue Doppler echocardiography about 45 cases at Abidjan institute of cardiology].
    Annales de cardiologie et d'angeiologie, 2013, Volume: 62, Issue:1

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents; Cardiomyopathies; Cardiotoxins; Developing Countries; Dose-Response Relationship, Drug; Doxorubicin; Echocardiography, Doppler; Epirubicin; Female; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Mitral Valve; Neoplasms; Stroke Volume; Systole; Togo; Ventricular Dysfunction, Left

2013
[Short and medium term cardiotoxicity of anthracyclins: a prospective study].
    Annales de cardiologie et d'angeiologie, 2012, Volume: 61, Issue:4

    Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Morocco; Myocardial Contraction; Myocarditis; Neoplasms; Prospective Studies; Risk Factors; Time Factors; Ultrasonography; Ventricular Dysfunction, Left

2012
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Fluorouracil; Heart; Humans; Incidence; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left

2006
Left ventricular diastolic performance in breast cancer survivors treated with anthracyclines.
    Acta cardiologica, 2008, Volume: 63, Issue:1

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Diastole; Echocardiography; Epirubicin; Female; Humans; Middle Aged; Ventricular Dysfunction, Left; Ventricular Function, Left

2008
Prospective evaluation of anthracycline-related early cardiac damage: how do we monitor it?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Nov-15, Volume: 19, Issue:22

    Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Epirubicin; Female; Heart; Humans; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Radionuclide Ventriculography; Ultrasonography; Ventricular Dysfunction, Left

2001